Page last updated: 2024-10-27

gentamicin and Leishmaniasis, Mucocutaneous

gentamicin has been researched along with Leishmaniasis, Mucocutaneous in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Leishmaniasis, Mucocutaneous: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schüle, D1
Braun, J1
Lüders, G1

Other Studies

1 other study available for gentamicin and Leishmaniasis, Mucocutaneous

ArticleYear
[Gentamicin in the treatment of cutaneous leishmaniasis].
    Zeitschrift fur Hautkrankheiten, 1974, Nov-15, Volume: 49, Issue:22

    Topics: Diagnosis, Differential; Emetine; Gentamicins; Histoplasmosis; Humans; Leishmaniasis, Mucocutaneous;

1974